Cristina De Min
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy and safety of emapalumab in macrophage activation syndrome.
Journal: Annals of the rheumatic diseases
Published: December 18, 2022
Persistently active interferon-γ pathway and expansion of T-bet+ B cells in a subset of patients with childhood-onset systemic lupus erythematosus.
Journal: European journal of immunology
Published: December 06, 2022
Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach.
Journal: British journal of clinical pharmacology
Published: May 24, 2021
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.
Journal: The New England journal of medicine
Published: May 07, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection.
Journal: Haematologica
Published: April 15, 2020
Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.
Journal: Annals of the rheumatic diseases
Published: October 16, 2019
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.
Journal: Hepatology communications
Published: December 03, 2017
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.
Journal: The Journal of allergy and clinical immunology
Published: October 07, 2016
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease.
Journal: Arthritis research & therapy
Published: May 10, 2016
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 18, 2016
Last Updated: 09/26/2026